| Literature DB >> 28018730 |
Michael Jermyn1, Joannie Desroches2, Jeanne Mercier2, Karl St-Arnaud2, Marie-Christine Guiot3, Frederic Leblond4, Kevin Petrecca5.
Abstract
Surgical treatment of brain cancer is limited by the inability of current imaging capabilities such as magnetic resonance imaging (MRI) to detect the entirety of this locally invasive cancer. This results in residual cancer cells remaining following surgery, leading to recurrence and death. We demonstrate that intraoperative Raman spectroscopy can detect invasive cancer cells centimeters beyond pathological T1-contrast-enhanced and T2-weighted MRI signals. This intraoperative optical guide can be used to detect invasive cancer cells and minimize post-surgical cancer burden. The detection of distant invasive cancer cells beyond MRI signal has the potential to increase the effectiveness of surgery and directly lengthen patient survival.Entities:
Keywords: (170.1610) Clinical applications; (170.5660) Raman spectroscopy; (170.6935) Tissue characterization
Year: 2016 PMID: 28018730 PMCID: PMC5175557 DOI: 10.1364/BOE.7.005129
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732